FDA Warning Letter — Carsgen Therapeutics Corporation
The FDA took a Warning Letter action against Carsgen Therapeutics Corporation on Jul 26, 2024 (Durham, NC). The action was issued by CBER and concerns biologics products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Carsgen Therapeutics Corporation
- Date
- Jul 26, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Center
- CBER
- Location
- Durham, NC (United States)